Rigel Pharmaceuticals

Rigel Pharmaceuticals Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing

Rigel Pharmaceuticals, Inc., is a biotechnology company dedicated to discovering, developing and commercializing novel small molecule drugs that significantly improve the lives of patients with hematologic disorders, cancer, and rare immune diseases. The company's first FDA-approved product is TAVALISSE® (fostamatinib disodium hexahydrate) tablets, the only oral spleen tyrosine kinase (SYK) inhibi

tor for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The product is also commercially available in Europe (TAVLESSE), the United Kingdom, and Canada (TAVALISSE) for the treatment of chronic immune thrombocytopenia in adult patients. Fostamatinib is currently being studied in a Phase 3 clinical trial (NCT03764618) for the treatment of warm autoimmune hemolytic anemia (wAIHA)1; a Phase 3 clinical trial (NCT04629703) for the treatment of hospitalized high-risk patients with mild-to-moderate COVID-191; an NIH/NHLBI-funded Phase 3 ACTIV-4 Host Tissue Study (NCT04924660) for the treatment of COVID-19 in hospitalized patients on oxygen therapy, and a Phase 2 clinical trial (NCT04581954) for the treatment of COVID-19 being conducted by Imperial College London. Rigel's other clinical programs include its interleukin receptor-associated kinase (IRAK) inhibitor program, and a receptor-interacting serine/threonine-protein kinase (RIPK) inhibitor program in clinical development with partner Eli Lilly and Company. In addition, Rigel has product candidates in development with partners BerGenBio ASA and Daiichi Sankyo. For further information, visit www.rigel.com or follow us on Twitter or LinkedIn.

This month, Rigel Pharmaceuticals is supporting our ITP community and the  for   month. Join us in driving ITP awareness...
09/01/2026

This month, Rigel Pharmaceuticals is supporting our ITP community and the for month. Join us in driving ITP awareness!

Today, we honor Juneteenth, a day that marks the end of slavery in the United States and celebrates the strength, resili...
06/19/2026

Today, we honor Juneteenth, a day that marks the end of slavery in the United States and celebrates the strength, resilience, and contributions of Black Americans throughout history.

At Rigel, we recognize that advancing innovation in healthcare requires diverse perspectives, equitable opportunities, and a commitment to serving all communities. As we reflect on the significance of this day, we reaffirm our dedication to fostering an inclusive workplace and helping improve health outcomes for all the patients we serve.

Every day, clinical research professionals navigate tightening budgets, evolving regulations, and rapidly shifting techn...
05/20/2026

Every day, clinical research professionals navigate tightening budgets, evolving regulations, and rapidly shifting technologies — all while keeping patients at the center of everything they do.

On , we thank these professionals, the patients who place their trust in the research and their families who continue to push forward.

To learn more: https://www.clinicaltrialsday.org/

This  , we rolled up our sleeves and got to work 🌎Our team came together to help clean up our community—because protecti...
04/29/2026

This , we rolled up our sleeves and got to work 🌎

Our team came together to help clean up our community—because protecting the planet starts with the actions we take close to home. Every piece picked up is a step toward a healthier, more sustainable future.

Today we recognize International Women’s Day — a celebration of generosity, collaboration, and the power of opportunity....
03/08/2026

Today we recognize International Women’s Day — a celebration of generosity, collaboration, and the power of opportunity.

When people, organizations, and communities give, support for women grows. When women thrive, we all rise.

Learn more: https://www.internationalwomensday.com/

FREE International Women's Day 2026 theme resources -

Happy Employee Appreciation Day 🧡 To our employees - thank you for your dedication, your passion, and the energy you bri...
03/06/2026

Happy Employee Appreciation Day 🧡

To our employees - thank you for your dedication, your passion, and the energy you bring to Rigel.

Our success is powered by our people — and today we celebrate you.

March 8 is International Women’s Day. 💜The   campaign theme, Give To Gain, reminds us that contributing to women’s advan...
03/05/2026

March 8 is International Women’s Day. 💜

The campaign theme, Give To Gain, reminds us that contributing to women’s advancement helps build a more supportive and interconnected world.

Together, let’s help forge gender equality. Learn more: https://www.internationalwomensday.com/

Tomorrow is Rare Disease Day.   raises awareness for the more than 300 million people worldwide living with a rare disea...
02/27/2026

Tomorrow is Rare Disease Day. raises awareness for the more than 300 million people worldwide living with a rare disease — along with their families and caregivers — and advocates for equitable access to diagnosis, treatment, and care. Learn more: https://www.rarediseaseday.org/what-is-rare-disease-day/

12/08/2025

We’re seeing the largest number of RSVPs ever for this year’s RET Research Update, and we hope you’ll be there too!

Join us on December 11 to hear the latest breakthroughs in RET-positive non-small cell lung cancer, updates from previously funded research, and what’s ahead. You’ll also get the first update from the Lung Cancer Genetics Study with Troper Wojcicki Philanthropies and the 23andMe Research Institute.

Have a question about RET-positive lung cancer? Submit it when you register. Our panel of experts will answer as many as they can, and we’ll share all responses after the event.

📅 December 11
🕒 12:30–2:30 pm

Register today: https://happylungsproject.org/2025-ret-research-webinar-registration/

Address

611 Gateway Boulevard, Suite 900
South San Francisco, CA
94080

Alerts

Be the first to know and let us send you an email when Rigel Pharmaceuticals posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Rigel Pharmaceuticals:

Shortcuts

Share